Compounds, composition, methods, targets for cancer therapy

Details for Australian Patent Application No. 2012203061 (hide)

Owner Yu, M.

Inventors Yu, Ming

Agent Madderns

Pub. Number AU-A-2012203061

Parent 2008272818

Filing date 24 May 2012

Wipo publication date 14 June 2012

International Classifications

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/353 (2006.01)

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 June 2012 Complete Application Filed

14 June 2012 Application Open to Public Inspection

  Published as AU-A-2012203061

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203062-Synthesis Process, and Crystalline Form of 4-{3-[cis-Hexahydrocyclopenta[c]pyrrol2(1H)-yl]propoxy}Benzamide Hydrochloride and Pharmaceutical Compositions Containing It

2012203060-Mobile device location estimation